BioSpace News Archive

Galectin Therapeutics Inc. announced the Company will be presenting at the H.C. Wainwright Global Investment Conference being held from May 23-26, 2022 and at the 5th Global NASH Congress in London, UK on May 26-27, 2022.

CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases, today announced that results from new analyses of clinical studies of seladelpar were presented during Digestive Disease Week® (DDW) .

Masimo announced the findings of a retrospective study published in the American Journal of Emergency Medicine in which Dr. Gülsah Demir and colleagues at Tepecik Research and Training Hospital in Izmir, Turkey investigated the potential ability of Masimo PVi® to guide emergency room triage decisions for pediatric patients with signs of obstructive respiratory disease, such as an asthma attack.

Orphazyme A/S in restructuring, a late-stage biopharmaceutical company, has previously announced its entry into an agreement with KemPharm Denmark A/S to sell substantially all of its assets and business activities and submission of the restructuring proposal to the Danish Maritime and Commercial High Court and the Company’s known creditors.

The Pennsylvania and Maryland Departments of Health have granted Immunovia, Inc., the US subsidiary of Immunovia AB, Clinical Laboratory permits, allowing physicians in Pennsylvania and Maryland to order the IMMray™ PanCan-d test for their patients.

Modra Pharmaceuticals announced that the company will present new data from its Phase 2b trial evaluating ModraDoc006/r, a boosted oral taxane therapeutic versus the standard-of-care IV chemotherapy docetaxel, in patients with metastatic Castration-Resistant Prostate Cancer at the upcoming ASCO General Annual Meeting held from June 3 – 7, 2022 virtually and in-person in Chicago, IL, USA.

Endotronix, Inc. announced positive data from the SIRONA 2 clinical trial evaluating safety and efficacy of its Cordella™ Pulmonary Artery Pressure Sensor System in New York Heart Association class III heart failure patients.

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced a seamless, cloud-based workflow that improves the spatial data analysis experience of customers using Illumina NextSeq™ 1000 and NextSeq™ 2000 sequencing systems and the GeoMx® Digital Spatial Profiler.

Modular Devices, a leading provider of mobile and modular medical imaging equipment labs and cleanroom solutions, and portfolio company of O2 Investment Partners, announced that it has partnered with Cardiac Services Mobile.

BioAge Labs, Inc. announced that BioAge chief business officer Peng Leong, PhD, MBA, has been appointed as the Company’s Head of Brain Aging.